Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127250823 | 12725082 | 3 | F | 20160720 | 20160902 | 20160908 | 20160915 | EXP | IT-MINISAL02-372360 | IT-TEVA-689411ACC | TEVA | 78.45 | YR | M | Y | 0.00000 | 20160915 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127250823 | 12725082 | 1 | PS | CARBOPLATINO TEVA - 10 MG/ML - TEVA PHARMA B.V. | CARBOPLATIN | 1 | 275 MG TOTAL | U | U | 77269 | 275 | MG | |||||||
| 127250823 | 12725082 | 2 | SS | NAVELBINE | VINORELBINE TARTRATE | 1 | 45 MG TOTAL | U | U | 0 | 45 | MG | SOLUTION FOR INFUSION | ||||||
| 127250823 | 12725082 | 3 | C | GRANISETRON KABI - 1MG/ML CONCENTRATO PER SOLUZIONE INIETTABILE/INFUSI | GRANISETRON | 1 | Intravenous (not otherwise specified) | 3 MG | U | 0 | 3 | MG | |||||||
| 127250823 | 12725082 | 4 | C | ZANTAC - 50 MG/5 ML SOLUZIONE INIETTABILE - GLAXOSMITHKLINE S.P.A. | 2 | Intravenous (not otherwise specified) | 50 MG | U | 0 | 50 | MG | ||||||||
| 127250823 | 12725082 | 5 | C | SOLDESAM - 4 MG/ML SOLUZIONE INIETTABILE - LABORATORIO FARMACOLOGICO M | 2 | Intravenous (not otherwise specified) | 8 MG | U | 0 | 8 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127250823 | 12725082 | 1 | Adenocarcinoma |
| 127250823 | 12725082 | 2 | Adenocarcinoma |
| 127250823 | 12725082 | 3 | Prophylaxis of nausea and vomiting |
| 127250823 | 12725082 | 4 | Prophylaxis of nausea and vomiting |
| 127250823 | 12725082 | 5 | Inflammation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127250823 | 12725082 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127250823 | 12725082 | Adrenal gland injury | |
| 127250823 | 12725082 | Hepatic lesion | |
| 127250823 | 12725082 | Pleural effusion | |
| 127250823 | 12725082 | Pulmonary embolism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127250823 | 12725082 | 1 | 20160627 | 20160627 | 0 | |
| 127250823 | 12725082 | 2 | 20160627 | 20160627 | 0 | |
| 127250823 | 12725082 | 3 | 20160627 | 20160627 | 0 | |
| 127250823 | 12725082 | 4 | 20160627 | 20160627 | 0 | |
| 127250823 | 12725082 | 5 | 20160627 | 20160627 | 0 |